48,860
edits
Difference between revisions of "Endometrial carcinoma"
Jump to navigation
Jump to search
m
→Clinical: evidence for tamoxifen
m (→Clinical: evidence for tamoxifen) |
|||
| Line 10: | Line 10: | ||
*Unopposed estrogen (polycystic ovarian syndrome (PCOS), anovulation, hormone replacement therapy (HRT)). | *Unopposed estrogen (polycystic ovarian syndrome (PCOS), anovulation, hormone replacement therapy (HRT)). | ||
*Tamoxifen use. | *Tamoxifen use. | ||
**Used for breast cancer; risk is quite small<ref name=pmid19505894>{{Cite journal | last1 = Brown | first1 = K. | title = Is tamoxifen a genotoxic carcinogen in women? | journal = Mutagenesis | volume = 24 | issue = 5 | pages = 391-404 | month = Sep | year = 2009 | doi = 10.1093/mutage/gep022 | PMID = 19505894 }}</ref> or possibly negligent.<ref name=pmid19827879>{{Cite journal | last1 = Ashraf | first1 = M. | last2 = Biswas | first2 = J. | last3 = Majumdar | first3 = S. | last4 = Nayak | first4 = S. | last5 = Alam | first5 = N. | last6 = Mukherjee | first6 = KK. | last7 = Gupta | first7 = S. | title = Tamoxifen use in Indian women--adverse effects revisited. | journal = Asian Pac J Cancer Prev | volume = 10 | issue = 4 | pages = 609-12 | month = | year = | doi = | PMID = 19827879 }}</ref> | |||
===Management=== | ===Management=== | ||